Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia
· Delayed Price · Currency is MYR 0.240
-0.020 (-7.69%)
At close: Mar 9, 2026
Pharmaniaga Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,574 | 1,869 | 512 | 555 | 714 | 969 | Upgrade
|
| Market Cap Growth | 241.22% | 265.25% | -7.79% | -22.28% | -26.35% | -25.92% | Upgrade
|
| Enterprise Value | 2,160 | 2,541 | 1,709 | 1,690 | 1,800 | 1,749 | Upgrade
|
| Last Close Price | 0.24 | 0.28 | 0.21 | 0.23 | 0.32 | 0.40 | Upgrade
|
| PE Ratio | 17.91 | 38.52 | 3.88 | - | - | 5.63 | Upgrade
|
| Forward PE | 12.97 | 20.65 | 10.60 | 24.06 | 11.24 | 11.53 | Upgrade
|
| PS Ratio | 0.40 | 0.48 | 0.14 | 0.16 | 0.21 | 0.20 | Upgrade
|
| PB Ratio | 3.43 | 4.07 | -3.51 | -2.02 | -2.05 | 2.06 | Upgrade
|
| P/TBV Ratio | 4.58 | 5.43 | - | - | - | 3.95 | Upgrade
|
| P/FCF Ratio | - | - | 44.46 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 11.99 | 11.82 | - | - | Upgrade
|
| PEG Ratio | - | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | Upgrade
|
| EV/Sales Ratio | 0.55 | 0.65 | 0.45 | 0.50 | 0.52 | 0.36 | Upgrade
|
| EV/EBITDA Ratio | 13.77 | 16.20 | 5.92 | 229.97 | 32.36 | 5.22 | Upgrade
|
| EV/EBIT Ratio | 16.66 | 19.60 | 6.55 | - | 64.27 | 5.69 | Upgrade
|
| EV/FCF Ratio | -45.49 | - | 148.48 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.79 | 1.79 | -8.17 | -4.35 | -3.35 | 1.82 | Upgrade
|
| Debt / EBITDA Ratio | 5.23 | 5.23 | 3.98 | 65.02 | 18.83 | 2.53 | Upgrade
|
| Debt / FCF Ratio | - | - | 103.57 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 1.22 | 1.22 | -7.24 | -3.92 | -3.19 | 1.70 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.58 | 3.58 | 3.66 | 146.13 | 19.98 | 2.38 | Upgrade
|
| Net Debt / FCF Ratio | -11.82 | -11.82 | 91.85 | -288.57 | -5.51 | -8.46 | Upgrade
|
| Asset Turnover | 1.85 | 1.85 | 1.92 | 1.81 | 1.70 | 2.51 | Upgrade
|
| Inventory Turnover | 5.24 | 5.24 | 5.39 | 4.60 | 3.09 | 4.52 | Upgrade
|
| Quick Ratio | 0.46 | 0.46 | 0.29 | 0.24 | 0.19 | 0.22 | Upgrade
|
| Current Ratio | 0.91 | 0.91 | 0.62 | 0.55 | 0.58 | 1.11 | Upgrade
|
| Return on Equity (ROE) | 32.36% | 32.36% | - | - | -1027.82% | 41.73% | Upgrade
|
| Return on Assets (ROA) | 3.82% | 3.82% | 8.35% | -0.68% | 0.85% | 10.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.30% | 9.10% | 21.02% | -2.62% | 2.76% | 16.94% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.40% | 20.40% | 665.10% | 23.30% | -12.70% | 38.90% | Upgrade
|
| Earnings Yield | 3.08% | 2.60% | 25.77% | -14.45% | -88.23% | 17.76% | Upgrade
|
| FCF Yield | -3.02% | -2.54% | 2.25% | -0.67% | -28.24% | -9.74% | Upgrade
|
| Dividend Yield | - | - | - | - | 5.86% | 23.18% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 34.24% | Upgrade
|
| Buyback Yield / Dilution | -150.74% | -150.74% | -5.38% | -4.40% | -0.05% | -0.04% | Upgrade
|
| Total Shareholder Return | -150.74% | -150.74% | -5.38% | -4.40% | 5.82% | 23.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.